P741: DDX41 MUTATIONS DEFINE A UNIQUE SUBTYPE OF MYELOID NEOPLASMS.

• H. Makishima,
• R. Saiki,
• Y. Nannya,
• S. Korotev,
• C. Gurnari,
• J. Takeda,
• Y. Momozawa,
• S. Best,
• P. Krishnamurthy,
• T. Yoshizato,
• Y. Atsuta,
• Y. Shiozawa,
• Y. Iijima-Yamashita,
• K. Yoshida,
• Y. Shiraishi,
• Y. Nagata,
• N. Kakiuchi,
• M. Onizuka,
• K. Chiba,
• H. Tanaka,
• A. Kon,
• Y. Ochi,
• M. Nakagawa,
• R. Okuda,
• T. Mori,
• H. Itonaga,
• Y. Miyazaki,
• M. Sanada,
• H. Tsurumi,
• S. Kasahara,
• C. Müller-Tidow,
• A. Takaori-Kondo,
• K. Ohyashiki,
• T. Kiguchi,
• F. Matsuda,
• J. Jansen,
• C. Polprasert,
• S. Miyano,
• L. Malcovati,
• T. Haferlach,
• M. Kubo,
• M. Cazzola,
• A. Kulasekararaj,
• L. Godley,
• J. Maciejewski,
• S. Ogawa

Affiliations

H. Makishima

1 Department of Pathology and Tumor Biology

R. Saiki

1 Department of Pathology and Tumor Biology

Y. Nannya

2 Kyoto University, Kyoto, Japan

S. Korotev

3 Departments of Medicine and Human Genetics, Section of Hematology/Oncology, The University of Chicago, Chicago

C. Gurnari

4 Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, United States of America

J. Takeda

1 Department of Pathology and Tumor Biology

Y. Momozawa

5 Laboratory for Genotyping Development, Center for Integrative Medical Sciences (IMS), RIKEN, Yokohama, Japan

S. Best

6 King’s College Hospital NHS Foundation Trust, London, United Kingdom

P. Krishnamurthy

6 King’s College Hospital NHS Foundation Trust, London, United Kingdom

T. Yoshizato

1 Department of Pathology and Tumor Biology

Y. Atsuta

7 Department of Healthcare Administration, Nagoya University Graduate School of Medicine

Y. Shiozawa

1 Department of Pathology and Tumor Biology

Y. Iijima-Yamashita

8 Department of Advanced Diagnosis, Clinical Research Center, Nagoya Medical Center, Nagoya

K. Yoshida

1 Department of Pathology and Tumor Biology

Y. Shiraishi

9 Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo

Y. Nagata

1 Department of Pathology and Tumor Biology

N. Kakiuchi

1 Department of Pathology and Tumor Biology

M. Onizuka

10 Department of Hematology and Oncology, Tokai University School of Medicine, Isehara

K. Chiba

9 Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo

H. Tanaka

9 Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo

A. Kon

1 Department of Pathology and Tumor Biology

Y. Ochi

1 Department of Pathology and Tumor Biology

M. Nakagawa

1 Department of Pathology and Tumor Biology

R. Okuda

1 Department of Pathology and Tumor Biology

T. Mori

1 Department of Pathology and Tumor Biology

H. Itonaga

11 Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki

Y. Miyazaki

11 Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki

M. Sanada

8 Department of Advanced Diagnosis, Clinical Research Center, Nagoya Medical Center, Nagoya

H. Tsurumi

12 Department of Hematology, Gifu University

S. Kasahara

13 Department of Hematology, Gifu Municipal Hospital, Gifu, Japan

C. Müller-Tidow

14 Heidelberg University Hospital, Heidelberg, Germany

A. Takaori-Kondo

15 Department of Hematology, Kyoto University, Kyoto

K. Ohyashiki

16 Department of Hematology, Tokyo Medical University, Tokyo

T. Kiguchi

17 Chugoku Central Hospital, Fukuyama

F. Matsuda

18 Center for Genomic Medicine, Kyoto University, Kyoto, Japan

J. Jansen

19 Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Nijmegen, Netherlands

C. Polprasert

20 Department of Medicine, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand

S. Miyano

9 Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo

L. Malcovati

21 Department of Molecular Medicine, University of Pavia, Pavia, Italy

T. Haferlach

22 MLL, Munich Leukemia Laboratory, Munich, Germany

M. Kubo

5 Laboratory for Genotyping Development, Center for Integrative Medical Sciences (IMS), RIKEN, Yokohama, Japan

M. Cazzola

21 Department of Molecular Medicine, University of Pavia, Pavia, Italy

A. Kulasekararaj

6 King’s College Hospital NHS Foundation Trust, London, United Kingdom

L. Godley

3 Departments of Medicine and Human Genetics, Section of Hematology/Oncology, The University of Chicago, Chicago

J. Maciejewski

4 Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, United States of America

S. Ogawa

1 Department of Pathology and Tumor Biology